Demographic and relevant clinical information for the enrolled study patients separated according to deceased donor kidney undergoing PPP vs. CSP.

*eGFR at the end of the study for each patient (minimal follow-up 24 months post-transplantation).Abbreviations: CIT = cold ischemia time, WIT/RVT = warm ischemia time/revascularization time, eGFR = estimated glomerular filtration rate, AA = African American, PRA = panel reactive antibodies, HCV = hepatitis C virus, CMV = cytomegalovirus, Estimated GFR (eGFR) was calculated using the abbreviated MDRD formula. P-values were calculated using Fisher's exact test.1All values are given as averages ± standard deviation if not otherwise stated.* 本研究中每位患者在研究终点的估算肾小球滤过率（estimated glomerular filtration rate, eGFR），要求移植术后最小随访时长为24个月。缩写说明：CIT为冷缺血时间（cold ischemia time, CIT），WIT/RVT为热缺血时间/血管再通时间（warm ischemia time/revascularization time, WIT/RVT），eGFR为估算肾小球滤过率，AA为非裔美国人（African American, AA），PRA为群体反应性抗体（panel reactive antibodies, PRA），HCV为丙型肝炎病毒（hepatitis C virus, HCV），CMV为巨细胞病毒（cytomegalovirus, CMV）。估算肾小球滤过率（eGFR）采用简化MDRD公式计算。P值通过Fisher精确检验计算。1 若无特殊说明，所有数值均以平均值±标准差形式给出。